MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H23021613

June 12, 2023

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(按C13H22N4O3S计)

化学药品

June 12, 2023

Company Information

Applicant Company

黑龙江省铁力市五一街东侧

Manufacturing Company

黑龙江省铁力市五一街东侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath